Story thread · 2 reports / 2 sources
Ratio Therapeutics secures $70m Series C funding for cancer radiotherapy
finance.yahoo.com · 8d
How the coverage leans
Across 2 sources · syndicated copies counted once
First report: Ratio collects $70M for its radiopharmaceutical trials; Vogenx plans $67M IPO — endpts.com, 11d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.